BMI View: Thailand's private healthcare providers will be well positioned for growth. Supporting this
trajectory is the country's popularity as a medical tourism destination, augmenting domestic demand for
medical services. Private hospitals also have the opportunity ..."
BMI View: Multinational drugmakers will continue to face a difficult business environment in Thailand.
Designated as a 'Priority Watch List Country' for PhRMA's Special 301 submission for 2016, key issues
highlighted in 2015 remain unaddressed. This includes low level ..."
BMI View: Developing into a regional hub for pharmaceutical R&D will remain a challenge for Thailand.
The government has yet to implement a national level strategy to foster the sector's growth and is unlikely
to do so in the short term as the military junta focuses o ..."
BMI View: Thailand's medical system will see a transformation. This comes as there is a growing
divergence between the three healthcare schemes in the country in terms of cost as well as healthcare
outcomes. In addition, the economy has taken a much stronger precedenc ..."
BMI View: Competitively priced medical services, government support of the healthcare sector and
Thailand's position as a popular holiday destination will continue to boost the growth of the country's
medical tourism industry. This will provide significant revenue ear ..."
BMI View: Thailand will continue to be an attractive location to international drug makers as a result of its
growing domestic pharmaceutical market with an ageing population and improving access to healthcare as
well as its position as an entry point into the frontier markets ..."
BMI View: The stability brought about from the Junta will mitigate the uncertainty weighing down
Thailand's pharmaceutical market. With its ageing population and universal healthcare, Thailand presents
good market opportunities though risks stemming from cost containm ..."
BMI View: Thailand offers several revenue earning opportunities to drugmakers due to its ageing
population and the presence of a universal healthcare system that provides the population with access to
healthcare. However cost containment policies and delays in patent ..."
BMI View: We believe that the current political impasse will not have a significant impact on healthcare provision in Thailand, and therefore our health expenditure projections will remain unchanged unless tensions escalate and cause a breakdown in medical services. We maintain t ..."
BMI View: We highlight the need for Thailand to address the issue of sustainability. A slowing economy
coupled with an ageing population will mean more financial outlays by the government in the
future. Heightened political risk is also an ongoing concern as any chang ..."